| human | Q5 |
| P185 | doctoral student | Stephanie Berger | Q110717373 |
| P108 | employer | University of Washington | Q219563 |
| P734 | family name | Hockenbery | Q37526719 |
| P735 | given name | David | Q18057751 |
| David | Q18057751 | ||
| M. | Q19803510 | ||
| M. | Q19803510 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | academic | Q3400985 |
| P5008 | on focus list of Wikimedia project | WikiProject PCC Wikidata Pilot/University of Washington | Q98970039 |
| P21 | sex or gender | male | Q6581097 |
| Q40109406 | 2-Methoxy antimycin reveals a unique mechanism for Bcl-x(L) inhibition |
| Q27684407 | A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells |
| Q54943565 | A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines. |
| Q44084514 | A mitochondrial Achilles' heel in cancer? |
| Q55042980 | A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. |
| Q114140922 | Abstract 1981: Immune related liver toxicity and potential risk factors: A case-control study |
| Q42626543 | Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation |
| Q27334982 | An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMS |
| Q91181138 | Analysis of the Myc-induced pancreatic β cell islet tumor microenvironment using imaging ToF-SIMS |
| Q31929631 | Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. |
| Q44422869 | BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation |
| Q79442727 | BCL-2 suppresses ceramide-induced cell killing |
| Q41126150 | BCL-2, a novel regulator of apoptosis |
| Q53964467 | BCL-XL dimerization by three-dimensional domain swapping |
| Q37572590 | BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death |
| Q83234009 | Bak to basics of colonocyte renewal |
| Q47721978 | Bcl-2 Slowsin VitroBreast Cancer Growth Despite Its Antiapoptotic Effect |
| Q37367025 | Bcl-2 family proteins as regulators of oxidative stress |
| Q29620401 | Bcl-2 functions in an antioxidant pathway to prevent apoptosis |
| Q29620000 | Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death |
| Q24308796 | Bcl-2 maintains B cell memory |
| Q43786849 | Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53. |
| Q35181299 | Bcl-2-related proteins as drug targets |
| Q83956281 | Bcl-2-related survival proteins |
| Q70237247 | Bcl-2: B cell life, death and neoplasia |
| Q27642316 | Bcl-XL Mutations Suppress Cellular Sensitivity to Antimycin A |
| Q40812422 | Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A. |
| Q34520569 | Blood and Gastric FOXP3+ T Cells Are Not Decreased in Human Gastric Graft-versus-Host Disease |
| Q40855442 | Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells |
| Q74664264 | Caspase-3 inhibits growth in Saccharomyces cerevisiae without causing cell death |
| Q92599539 | Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans |
| Q37597636 | Competitive inhibition of benzodiazepine binding by fractions from porcine brain |
| Q37452081 | Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer |
| Q37229088 | Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism. |
| Q41559705 | Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis |
| Q37363034 | Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells |
| Q40593643 | Defining apoptosis |
| Q41735487 | Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. |
| Q40135330 | Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines |
| Q37103897 | Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals |
| Q28507620 | Disruption of Fnip1 Reveals a Metabolic Checkpoint Controlling B Lymphocyte Development |
| Q74378341 | Distinct Alterations in Mitochondrial Mass and Function Characterize Different Models of Apoptosis |
| Q41119415 | Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. |
| Q41454845 | Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. |
| Q33227072 | Efficacy of neodymium:YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant |
| Q37340468 | Endothelial inflammation induced by excess glucose is associated with cytosolic glucose 6-phosphate but not increased mitochondrial respiration |
| Q48145247 | Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides. |
| Q28593316 | Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene |
| Q41594467 | Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases |
| Q41038244 | Flow cytometric measurement of mitochondrial mass and function: A novel method for assessing chemoresistance |
| Q34985419 | Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy |
| Q87403609 | Forecast: rough seas for leukemia |
| Q46916861 | Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome |
| Q35932266 | HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition |
| Q33303676 | Hsp90 inhibition decreases mitochondrial protein turnover |
| Q24806811 | Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells |
| Q40168272 | Identification of genes with abnormal expression changes in acute myeloid leukemia |
| Q67939380 | Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms |
| Q40401154 | Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas. |
| Q33934809 | Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells |
| Q54117207 | Inhibition of vaccinia virus replication by nitazoxanide |
| Q35594851 | Intracellular delivery system for antibody-Peptide drug conjugates |
| Q34474389 | Investigating Neoplastic Progression of Ulcerative Colitis with Label-Free Comparative Proteomics |
| Q33687406 | Life and death in otolaryngology: mechanisms of apoptosis and its role in the pathology and treatment of disease |
| Q36004758 | Lipid analysis of eight human breast cancer cell lines with ToF-SIMS. |
| Q40134910 | Loss of FANCC function is associated with failure to inhibit late firing replication origins after DNA cross-linking |
| Q55500213 | Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation. |
| Q77078761 | Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation |
| Q42988328 | MMPs in unusual places |
| Q37717928 | MYC and mitochondrial biogenesis |
| Q71789640 | Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand |
| Q36882685 | Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program |
| Q34956201 | Mitochondria and apoptosis: new therapeutic targets |
| Q41098628 | Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line |
| Q38857334 | Mitochondrial functions in stem cells |
| Q42259199 | Mutant IDH1 regulates the tumor-associated immune system in gliomas |
| Q35107138 | Myc's Mastery of Mitochondrial Mischief |
| Q34298938 | Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry |
| Q93523390 | Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry |
| Q70796814 | Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease |
| Q74739113 | Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: A randomized, controlled trial |
| Q43061699 | Oral beclomethasone dipropionate in gastrointestinal graft-versus-host disease |
| Q62654663 | Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism |
| Q52724734 | Pathological assessment of gastrointestinal biopsies from patients with idelalisib-associated diarrhea and colitis |
| Q68169566 | Pericrypt eosinophilic enterocolitis and chronic diarrhea |
| Q38619812 | Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease |
| Q40602482 | Prevention of Fas-mediated hepatic failure by transferrin |
| Q71702546 | Primitive human hematopoietic precursors express Bcl-x but not Bcl-2 |
| Q45104194 | Reactive oxygen species in chick hair cells after gentamicin exposure in vitro |
| Q34978857 | Reduced Cytochrome c Is an Essential Regulator of Sustained Insulin Secretion by Pancreatic Islets |
| Q46361757 | Response of Steroid-Refractory Acute GVHD to α1-Antitrypsin |
| Q73572579 | Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome |
| Q36702040 | Small-molecule inhibitors of Bcl-2. |
| Q96591081 | Spontaneous Tumor Regression in Tasmanian Devils Associated with RASL11A Activation |
| Q73401130 | Successful medical treatment of intestinal ulceration caused by Rhizopus microsporus |
| Q36294095 | Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix–induced apoptosis |
| Q40138909 | Targeted therapies for epithelial cancers: in vivo efficacy of the BCL-2/BCL-XL inhibitor 2-MeAA. |
| Q83158104 | Targeting mitochondria for cancer therapy |
| Q37162513 | The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins |
| Q35178204 | The bcl-2 oncogene and apoptosis |
| Q36327765 | The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition |
| Q28580062 | The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry |
| Q73383538 | The role of apoptosis during intestinal adaptation after small bowel resection |
| Q35082945 | ToF-SIMS of tissues: "lessons learned" from mice and women |
| Q34608393 | Warburg and Crabtree Effects in Premalignant Barrett's Esophagus Cell Lines with Active Mitochondria |
| Q40608626 | bcl-2 in cancer, development and apoptosis. |
| Q44192187 | bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes |
| Q40466009 | bcl‐2, a novel reguator of cell death |
| Q35963815 | c-MYC apoptotic function is mediated by NRF-1 target genes |
| Q37427003 | c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry |
| Q34431458 | α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics |
| Q110717373 | Stephanie Berger | doctoral advisor | P184 |
| Q110719002 | Controlling Apoptosis With Computationally Designed Inhibitors Targeting Pro-survival and Pro-apoptosis Bcl2 Family Members | thesis committee member | P9161 |
Search more.